CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Grant or award CSO/EVP Disc & Trans Research acquired 132,819 shares (grant or award)
- 4 Grant or award EVP & General Counsel acquired 154,070 shares (grant or award)
- 4 Grant or award EVP, Commercial acquired 159,383 shares (grant or award)
- 4 Grant or award EVP and CFO acquired 170,009 shares (grant or award)
- 4 Planned sale EVP, Commercial sold 10,000 shares at $38.80 ($388,000)
- 4 Open-market sale Director sold 73,808 shares at an average $38.00 ($2,804,459)
- 4 Grant or award President and CEO acquired 184,909 shares (grant or award)
- 4 Grant or award CSO/EVP Disc & Trans Research acquired 49,209 shares (grant or award)
- 4 Grant or award EVP, Commercial acquired 47,718 shares (grant or award)
- 4 Grant or award EVP & General Counsel acquired 52,192 shares (grant or award)
- 4 Grant or award EVP Prod Dev & Med Aff & CMO acquired 52,192 shares (grant or award)
- 4 Planned sale Director sold 8,768 shares at $37.80 ($331,430)
- 4 Grant or award EVP and CFO acquired 59,648 shares (grant or award)
- 4 Open-market sale EVP, Commercial sold 52,636 shares at $36.98 ($1,946,479)
- 4 Open-market sale Director sold 18,647 shares at $37.25 ($694,601)
- 4 Open-market sale CSO/EVP Disc & Trans Research sold 26,987 shares at $36.75 ($991,772)
- 4 Gift President and CEO gave 177,985 shares (gift)
- 4 Open-market sale EVP and CFO sold 29,314 shares at $36.14 ($1,059,408)
- 4 Shares withheld for taxes EVP and CFO gave up 21,591 shares (to pay taxes)
- 4 Open-market sale Director sold 12,210 shares at an average $34.88 ($425,878)
Page 5 of 73 · 1,458 filings